Antisense Therapeutics
Westpac woes stymie ASX bull run
WISR
Top broker rates this ASX neo-lender a buy
Bellevue Gold
Bellevue still looking for edges of deep Deacon discovery
Kingston Resources
Abi prospect could also contribute to Misima starter pit
Antisense Therapeutics (ASX:ANP) receives positive data from phase II ATL1102 DMD trial
Oklo Resources
Oklo Resources intersects more wide zones of gold mineralisation at Seko
Starpharma Holdings
Medical Developments International
Immutep
Pharmaxis
Ellex Medical Lasers
Prescient Therapeutics
Biotech stocks to watch in 2020
Clinical trial confirms Antisense Therapeutics drug can inhibit progression of Duchenne muscular dystrophy
Core Lithium
Todd River Resources
Core Lithium completes strategic acquisition of new NT lithium project
Australian Potash
Australian Potash advances feed program with $1.6m placement